GCM Grosvenor is a global alternative asset management firm that focuses on a diversified range of investment strategies including private equity, infrastructure, real estate, credit, and absolute return strategies. The firm also employs an "Elevate" strategy, which involves providing catalytic seed investments to emerging private equity firms, particularly those focused on lower and middle-market buyout opportunities.
100% of their portfolio is in Healthcare. Their most common stage is series-c (100% of deals).
Portfolio
1
Fund Size
$91B
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Enable Injections, Inc. | Series C | $215M | Jan 2022 |
Top Co-Investors
Last updated: 4 May 2026